The following is a summary of “Effect of different maneuvers of repositioning on benign paroxysmal vertigo: a network ...

Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...

The Ministry of Health (SSA) reported a significant increase in whooping cough cases in Mexico during the first two months of ...

Sarepta will update Elevidys’ label after a patient died following treatment; the FDA issues flu vaccine recommendations ...

Living with BPPV means navigating a world where severe dizziness can strike without warning, disrupting everyday life. Senior ...

Spherix Global Insights recently released its latest findings from RealTime Dynamix™: Paroxysmal Nocturnal Hemoglobinuria Q1 2025 (US) an independent tracking study based on insights from 51 U.S.

Benign paroxysmal positional vertigo (BPPV) is a type of vertigo caused by calcium crystals in the inner ear. These crystals are usually located in two parts of the ear called the utricle and saccule.

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

Benign paroxysmal positional vertigo (BPPV) is a type of vertigo caused by calcium crystals in the inner ear. These crystals are usually located in two parts of the ear called the utricle and saccule.

The Hass Avocado Board teamed up with the University of Eastern Finland researchers to examine the relationship between ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...